持田製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2016/12/01 | 8,030 | 8,050 | 7,920 | 7,960 | +10 | +0.1% | 26,500 |
2016/11/30 | 8,010 | 8,020 | 7,930 | 7,950 | -110 | -1.4% | 33,000 |
2016/11/29 | 8,040 | 8,070 | 8,010 | 8,060 | +20 | +0.2% | 20,900 |
2016/11/28 | 8,010 | 8,060 | 7,930 | 8,040 | -30 | -0.4% | 27,300 |
2016/11/25 | 8,040 | 8,110 | 7,980 | 8,070 | +30 | +0.4% | 31,200 |
2016/11/24 | 8,200 | 8,210 | 8,010 | 8,040 | -110 | -1.3% | 17,300 |
2016/11/22 | 8,050 | 8,180 | 8,050 | 8,150 | +30 | +0.4% | 13,600 |
2016/11/21 | 8,070 | 8,160 | 8,070 | 8,120 | +60 | +0.7% | 13,700 |
2016/11/18 | 8,130 | 8,200 | 8,050 | 8,060 | -60 | -0.7% | 13,600 |
2016/11/17 | 8,000 | 8,130 | 8,000 | 8,120 | +10 | +0.1% | 13,500 |
2016/11/16 | 8,180 | 8,190 | 8,040 | 8,110 | +30 | +0.4% | 27,100 |
2016/11/15 | 8,090 | 8,130 | 8,020 | 8,080 | -30 | -0.4% | 18,100 |
2016/11/14 | 8,130 | 8,220 | 8,100 | 8,110 | -120 | -1.5% | 15,600 |
2016/11/11 | 8,160 | 8,310 | 8,160 | 8,230 | +110 | +1.4% | 47,300 |
2016/11/10 | 8,100 | 8,130 | 8,000 | 8,120 | +420 | +5.5% | 30,000 |
2016/11/09 | 7,900 | 8,030 | 7,610 | 7,700 | -210 | -2.7% | 42,800 |
2016/11/08 | 8,090 | 8,130 | 7,890 | 7,910 | -140 | -1.7% | 22,100 |
2016/11/07 | 7,970 | 8,080 | 7,970 | 8,050 | +100 | +1.3% | 29,400 |
2016/11/04 | 8,100 | 8,100 | 7,860 | 7,950 | -180 | -2.2% | 39,600 |
2016/11/02 | 8,280 | 8,280 | 8,060 | 8,130 | -200 | -2.4% | 31,900 |
2016/11/01 | 8,320 | 8,360 | 8,230 | 8,330 | +100 | +1.2% | 32,400 |
2016/10/31 | 8,360 | 8,440 | 8,230 | 8,230 | -130 | -1.6% | 43,500 |
2016/10/28 | 8,400 | 8,420 | 8,230 | 8,360 | +10 | +0.1% | 49,100 |
2016/10/27 | 8,240 | 8,360 | 8,240 | 8,350 | +80 | +1% | 35,500 |
2016/10/26 | 8,270 | 8,280 | 8,180 | 8,270 | ±0 | ±0% | 22,300 |
2016/10/25 | 8,190 | 8,280 | 8,160 | 8,270 | +130 | +1.6% | 30,100 |
2016/10/24 | 8,180 | 8,210 | 8,100 | 8,140 | -80 | -1% | 41,400 |
2016/10/21 | 8,240 | 8,250 | 8,180 | 8,220 | -110 | -1.3% | 31,000 |
2016/10/20 | 8,190 | 8,330 | 8,180 | 8,330 | +50 | +0.6% | 32,100 |
2016/10/19 | 8,330 | 8,360 | 8,250 | 8,280 | -80 | -1% | 34,800 |
2016/10/18 | 8,300 | 8,410 | 8,270 | 8,360 | +210 | +2.6% | 49,000 |
2016/10/17 | 8,060 | 8,160 | 8,050 | 8,150 | +60 | +0.7% | 23,200 |
2016/10/14 | 8,150 | 8,180 | 8,070 | 8,090 | -110 | -1.3% | 20,500 |
2016/10/13 | 8,160 | 8,200 | 8,060 | 8,200 | +120 | +1.5% | 27,700 |
2016/10/12 | 8,060 | 8,150 | 7,980 | 8,080 | -20 | -0.2% | 27,600 |
2016/10/11 | 8,070 | 8,120 | 8,040 | 8,100 | +20 | +0.2% | 14,900 |
2016/10/07 | 8,030 | 8,100 | 8,020 | 8,080 | -40 | -0.5% | 23,300 |
2016/10/06 | 8,210 | 8,210 | 8,080 | 8,120 | -30 | -0.4% | 24,300 |
2016/10/05 | 8,220 | 8,230 | 8,140 | 8,150 | +100 | +1.2% | 38,700 |
2016/10/04 | 7,970 | 8,110 | 7,910 | 8,050 | +140 | +1.8% | 42,800 |
2016/10/03 | 7,970 | 7,970 | 7,790 | 7,910 | +10 | +0.1% | 77,200 |
2016/09/30 | 7,900 | 7,990 | 7,870 | 7,900 | -200 | -2.5% | 57,500 |
2016/09/29 | 8,100 | 8,180 | 8,000 | 8,100 | -90 | -1.1% | 61,800 |
2016/09/28 | 8,280 | 8,290 | 8,130 | 8,190 | -160 | -1.9% | 32,300 |
2016/09/27 | 8,270 | 8,350 | 8,130 | 8,350 | -10 | -0.1% | 56,300 |
2016/09/26 | 8,400 | 8,440 | 8,340 | 8,360 | ±0 | ±0% | 29,700 |
2016/09/23 | 8,100 | 8,370 | 8,030 | 8,360 | +200 | +2.5% | 123,000 |
2016/09/21 | 8,080 | 8,220 | 8,020 | 8,160 | +40 | +0.5% | 69,700 |
2016/09/20 | 8,000 | 8,190 | 7,950 | 8,120 | +90 | +1.1% | 44,400 |
2016/09/16 | 8,000 | 8,080 | 7,990 | 8,030 | +50 | +0.6% | 45,400 |
1951~
2000
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「持田薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
持田薬 | 331,500円 | +3.0% | +27.5% | 2.41% | 20.99倍 | 0.91倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
ジーエヌアイ | 281,400円 | +52.1% | +23.3% | 0.00% | 19.98倍 | 3.83倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
鳥居薬 | 476,000円 | +12.0% | +28.1% | 2.52% | 26.24倍 | 1.11倍 |
|
JT傘下。柱の抗HIV薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
ゼリア新薬 | 224,400円 | +13.6% | +29.2% | 2.05% | 11.64倍 | 1.12倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
ネクセラファーマ | 113,200円 | +197.7% | - | 0.00% | 46.26倍 | 1.48倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
市場注目の銘柄
チャート関連のコラム